Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T18477 | Target Info | |||
Target Name | Heat shock protein 90 alpha (HSP90A) | ||||
Synonyms | Renal carcinoma antigen NY-REN-38; Lipopolysaccharide-associated protein 2; LPS-associated protein 2; LAP-2; Heat shock protein HSP 90-alpha; Heat shock 86 kDa; HSPCA; HSPC1; HSP90A; HSP86; HSP 86 | ||||
Target Type | Successful Target | ||||
Gene Name | HSP90AA1 | ||||
Biochemical Class | Heat shock protein | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (E)-9-(But-2-en-1-yl)-8-(3,4,5-trimethoxybenzyl)-9H-purin-6-amine | Ligand Info | |||
Canonical SMILES | CC=CCN1C(=NC2=C(N=CN=C21)N)CC3=CC(=C(C(=C3)OC)OC)OC | ||||
InChI | 1S/C19H23N5O3/c1-5-6-7-24-15(23-16-18(20)21-11-22-19(16)24)10-12-8-13(25-2)17(27-4)14(9-12)26-3/h5-6,8-9,11H,7,10H2,1-4H3,(H2,20,21,22)/b6-5+ | ||||
InChIKey | ZAFMHPQRCYVTLV-AATRIKPKSA-N | ||||
PubChem Compound ID | 44376524 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6OLX Hsp90-alpha S52A bound to PU-11-trans | ||||||
Method | X-ray diffraction | Resolution | 1.44 Å | Mutation | Yes | [1] |
PDB Sequence |
EVETFAFQAE
25 IAQLMSLIIN35 TFYSNKEIFL45 RELISNASDA55 LDKIRYESLT65 DPSKLDSGKE 75 LHINLIPNKQ85 DRTLTIVDTG95 IGMTKADLIN105 NLGTIAKSGT115 KAFMEALQAG 125 ADISMIGQFG135 VGFYSAYLVA145 EKVTVITKHN155 DDEQYAWESS165 AGGSFTVRTD 175 TGEPMGRGTK185 VILHLKEDQT195 EYLEERRIKE205 IVKKHSQFIG215 YPITLFVEK |
|||||
|
||||||
PDB ID: 6N8X Hsp90-alpha bound to PU-11-trans | ||||||
Method | X-ray diffraction | Resolution | 1.49 Å | Mutation | No | [1] |
PDB Sequence |
EVETFAFQAE
25 IAQLMSLIIN35 TFYSNKEIFL45 RELISNSSDA55 LDKIRYESLT65 DPSKLDSGKE 75 LHINLIPNKQ85 DRTLTIVDTG95 IGMTKADLIN105 NLGTIAKSGT115 KAFMEALQAG 125 ADISMIGQFG135 VGFYSAYLVA145 EKVTVITKHN155 DDEQYAWESS165 AGGSFTVRTD 175 TGEPMGRGTK185 VILHLKEDQT195 EYLEERRIKE205 IVKKHSQFIG215 YPITLFVEKE 225
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structures of Hsp90Alpha and Hsp90beta bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity. Proteins. 2019 Oct;87(10):869-877. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.